Testicular cancer: who works on it

One card per institution. Pick a target or a country to narrow the list.

• All targets
• PD-1 1
• AXL 1
• DLL3 1
• GPC3 1
• HER2 1
• PD-L1 1
• VEGF 0

Funded research projects that name this disease in their title, terms or summary and have not ended yet: who is funded, where, how much and until when. Organisations only; the funder's page has the details.

No running funded project names this disease yet.

Sources: NIH RePORTER (U.S. National Institutes of Health, public domain) and CORDIS (European Commission, CC BY 4.0). Changes: filtered by disease, organisations matched to ROR.

Terminated, withdrawn and suspended trials with the reason the sponsor gave in the registry, quoted word for word.

• Suspended

  7 Tesla MRI Neuroimaging in Testicular Cancer Patients With Hypogonadism and on Androgen Replacement Therapy

  NCT06191575· University of Southern California· Updated 5 Jun 2026

  “Study team is conducting interim analysis.”Registry text, quoted unchanged. Source

• Withdrawn

  A Clinical Study Investigating the Therapeutic Effects and Safety of an Investigational Cell Therapy Given With and Without an Additional Investigational Product in Males With Testicular Cancer or a Form of Cancer That Developed From Sperm

  NCT06940804· BioNTech SE· Updated 2 Jul 2025

  “Sponsor decision”Registry text, quoted unchanged. Source

• Terminated

  Associations Between Chemotherapy-Induced Nausea in Patients With Genitourinary, Sarcoma or Melanoma Cancers and Changes in Gut Microbiome: Potential for Precision Therapeutics

  NCT05819827· Mayo Clinic· Updated 27 Apr 2025

  “Low/slow accrual”Registry text, quoted unchanged. Source

• Terminated

  A Study of SGN-ALPV in Advanced Solid Tumors

  NCT05229900· Seagen Inc.· Updated 10 Feb 2025

  “Study closed due to portfolio prioritization”Registry text, quoted unchanged. Source

• Withdrawn

  A Study of ASP1893 in Adults With Advanced CLDN6-positive Solid Tumors

  NCT06681870· Astellas Pharma Global Development, Inc.· Updated 15 Jan 2025

  “A business decision was made to not initiate this study.”Registry text, quoted unchanged. Source

Trials whose registry record says individual participant data (IPD) will be shared.

• Personalized Cancer Support (Thrive Track) to Manage the Emotional Needs of Young Adults With Thyroid, Melanoma and Testicular Cancer, PerCS-YA Trial

  NCT07529080· University of Michigan Rogel Cancer Center· Source

• Effects of Testicular Self-Examination Training Methods on Students' Behaviors and Health Beliefs

  NCT07841041· Yeditepe University· Source

• Pursuing Exploration Into the Supportive Care Needs and Intervention Preferences of Survivors of Testicular Cancer

  NCT07228637· Indiana University· Source

• A Novel Imaging Protocol in Use to Identify Lymph Nodes and Organs of Interest

  NCT05899361· Brigham and Women's Hospital· Source

• DESTINY-PANTUMOUR04

  NCT07124000· AstraZeneca· Source

• Integrated Cancer Repository for Cancer Research

  NCT02012699· University of Nebraska· Source

• Enhancing Readability of Lay Abstracts and Summaries for Medical Knowledge Using Generative Artificial Intelligence (BRIDGE AI 3)

  NCT07568444· University of Southern California· Source

• Primary RPLND Versus Systemic Chemotherapy in Good-prognosis Metastatic Testicular Cancer

  NCT07498959· Sahlgrenska University Hospital· Source

• Circulating microRNAs in Small Testicular Masses and Retroperitoneal Post-chemotherapy Residual Masses.

  NCT06620016· IRCCS Azienda Ospedaliero-Universitaria di Bologna· Source

Find publications on this disease by a MeSH method term, for example a sequencing or imaging method.

See which targets of this disease your abstract mentions, and go to the people working on them.